With the analysis among 882 patents, we discovered top 159 key players by total patent application. Regeneron Pharmaceuticals, Inc., Novartis AG, Rigel Pharmaceuticals, Inc. are dominant in this area. They take 29.25% of the total patent filing.
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 168
Basel-Stadt, Switzerland
Patent: 45
Rigel Pharmaceuticals, Inc.
California, United States
Patent: 45
Protagonist Therapeutics, Inc.
Queensland, Australia
Patent: 35
Chugai Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 23
Hanmi Pharmaceutical Co., Ltd.
F. Hoffmann-La Roche Ltd.
Suzhou Conrad Biomedicine Co Ltd
Jiangsu Sheng, China
Patent: 16
California, United States
Patent: 15
With the analysis among 26 patents, we discovered top 7 start-ups by total patent application. Jiangsu Quanxin Biomedical Co Ltd, Institut National de la Santé et de la Recherche Médicale, Bluefin Biomedicine, Inc. are active in this area.
Jiangsu Quanxin Biomedical Co Ltd
Jiangsu Sheng, China
Patent: 10
Institut National de la Santé et de la Recherche Médicale
Bluefin Biomedicine, Inc.
Massachusetts, United States
Patent: 4
Kanagawa-ken, Japan
Patent: 2
Leto Laboratories Co., Ltd.
Beijing Shi, China
Patent: 1
Dianomi Therapeutics, Inc.
Colorado, United States
Patent: 1
With the analysis among related 465 patents applied in the last 5 years. We discover 128 most active companies in this area. The fast-growing Regeneron Pharmaceuticals, Inc., Novartis AG, Protagonist Therapeutics, Inc. take 26.45% of patent filing during this period.
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 57
Basel-Stadt, Switzerland
Patent: 38
Protagonist Therapeutics, Inc.
Queensland, Australia
Patent: 28
Rigel Pharmaceuticals, Inc.
California, United States
Patent: 23
Hanmi Pharmaceutical Co., Ltd.
Suzhou Conrad Biomedicine Co Ltd
Jiangsu Sheng, China
Patent: 13
Jiangsu Quanxin Biomedical Co Ltd
Jiangsu Sheng, China
Patent: 10
Glaxosmithkline Intellectual Property Development Ltd.
East Sussex, United Kingdom
Patent: 10
With the analysis among related 465 patents in last 5 years, we discover 87 new entrants. Jiangsu Quanxin Biomedical Co Ltd, Glaxosmithkline Intellectual Property Development Ltd., 23andMe, Inc. are the most active new entrants in this area.
Jiangsu Quanxin Biomedical Co Ltd
Jiangsu Sheng, China
Patent: 10
Glaxosmithkline Intellectual Property Development Ltd.
East Sussex, United Kingdom
Patent: 10
California, United States
Patent: 9
Bio-Thera Solutions, Ltd.
Guangdong Sheng, China
Patent: 8
Centre hospitalier régional universitaire de Besançon(CHU de Besançon)
Université de Franche-Comté
undefined undefined
Patent: 6
Institut National de la Santé et de la Recherche Médicale
California, United States
Patent: 5
Établissement Français du Sang
With the analysis among 138 patents, we discovered top 34 universities and scientific research institutions by total patent application. University of Connecticut, University of Miami, Australian National University are dominant in this area. They take 29.71% of the total patent filing.
University of Connecticut
Connecticut, United States
Patent: 21
Australian National University
Australian Capital Territory, Australia
Patent: 6
Université de Franche-Comté
New York, United States
Patent: 4
Shanghai Shi, China
Patent: 4
Nordrhein-Westfalen, Germany
Patent: 3
Université Pierre et Marie Curie